The testing solutions for the detection of SARS-CoV-2
DiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated scientists DiaSorin has been able to promptly deliver diagnostic solutions to manage the COVID-19 pandemic emergency.
DiaSorin provides diagnostic laboratories with solutions that include detection of SARS-CoV-2 Ag, antibodies determination and molecular testing:
A high-quality tool to verify immune responses of vaccinated individuals
DiaSorin is supporting Public Health Systems confirm the efficacy of their vaccination strategy with a cost-effective, automated, high-throughput SARS-CoV-2 serology testing solution.
Emergency Use Authorization
Health Care Professional Fact Sheet
Patient Fact Sheet
Instructions For Use (IFU)